The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence.
Maria Vittoria Dieci
No relevant relationships to disclose
Elena Barbieri
No relevant relationships to disclose
Aicha Goubar
No relevant relationships to disclose
Fabrice Andre
No relevant relationships to disclose
Claudia Omarini
No relevant relationships to disclose
Stefania Raffaella Bettelli
No relevant relationships to disclose
Federico Piacentini
No relevant relationships to disclose
Guido Ficarra
No relevant relationships to disclose
Pier Franco Conte
No relevant relationships to disclose
Valentina Guarneri
No relevant relationships to disclose